サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Global Prostate Cancer Market (by Cancer Type, Drug, Therapy & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

世界の前立腺がん市場:洞察と予測、COVOD-19の潜在的影響(2020−2024)

レポート概要

世界の前立腺がん市場は2024年に144億1,000万ドルに達し、2020−2024年のCAGRは4.62%と予想されます。高齢者人口の増加、医療費の増加、肥満人口の増加、都市化の拡大、新薬の承認などがこの市場の成長をけん引するでしょう。一方で、治療薬の重篤な副作用、高額な治療費と長期にわたる治療期間といった課題もあります。注目すべき動向としては、医薬品産業の拡大、前立腺がんの負担の増大、オンコロジーにおける進歩が挙げられます。

世界の前立腺がん市場は、がんの種類別、治療薬&治療法別に分類されます。がんの種類別には大きくホルモン不応性前立腺癌、ホルモン感受性前立腺癌、その他の前立腺癌に分類されます。医薬品別には、Enzalutamide、Abiraterone Acetate、Leuprorelinに分けられます。治療法別には、化学療法、標的療法、免疫療法、ホルモン療法、その他の治療法があります。

レポート詳細

目次

1. Market Overview
1.1 Introduction
1.2 Types of Prostate Cancer
1.3 Staging and Grading
1.4 Symptoms of Prostate Cancer
1.5 Diagnosis of Prostate Cancer
1.6 Methods of Treatment
1.7 Risk Factors for Prostate Cancer

2. Impact of COVID-19
2.1 Impact on Prostate Cancer Market
2.2 Impact on Cancer Prevalence
2.3 Risk Factors for Severe Adverse Events
2.4 Management of Prostate Cancer Patients During the COVID-19

3. Global Market Analysis
3.1 Global Prostate Cancer Market by Value
3.2 Global Prostate Cancer Market Forecast by Value
3.3 Global Prostate Cancer Market by Cancer Type
3.3.1 Global Hormone Refractory Prostate Cancer Market by Value
3.3.2 Global Hormone Refractory Prostate Cancer Market Forecast by Value
3.3.3 Global Hormone Sensitive Prostate Cancer Market by Value
3.3.4 Global Hormone Sensitive Prostate Cancer Market Forecast by Value
3.4 Global Prostate Cancer Market by Drug
3.4.1 Global Enzalutamide Prostate Cancer Market by Value
3.4.2 Global Enzalutamide Prostate Cancer Market Forecast by Value
3.4.3 Global Abiraterone Acetate Prostate Cancer Market by Value
3.4.4 Global Abiraterone Acetate Prostate Cancer Market Forecast by Value
3.4.5 Global Leuprorelin Prostate Cancer Market by Value
3.4.6 Global Leuprorelin Prostate Cancer Market Forecast by Value
3.5 Global Prostate Cancer Market by Therapy
3.5.1 Global Chemotherapy Prostate Cancer Market by Value
3.5.2 Global Chemotherapy Prostate Cancer Market Forecast by Value
3.5.3 Global Targeted Therapy Prostate Cancer Market by Value
3.5.4 Global Targeted Therapy Prostate Cancer Market Forecast by Value
3.5.5 Global Immunotherapy Prostate Cancer Market by Value
3.5.6 Global Immunotherapy Prostate Cancer Market Forecast by Value
3.5.7 Global Hormonal Therapy Prostate Cancer Market by Value
3.5.8 Global Hormonal Therapy Prostate Cancer Market Forecast by Value
3.6 Global Prostate Cancer Market by Region

4. Regional Market Analysis
4.1 North America
4.1.1 North America Prostate Cancer Market by Value
4.1.2 North America Prostate Cancer Market Forecast by Value
4.1.3 The U.S. Prostate Cancer Market by Value
4.1.4 The U.S. Prostate Cancer Market Forecast by Value
4.1.5 The U.S. Prostate Cancer Market by Drug
4.1.6 The U.S. Enzalutamide Prostate Cancer Market by Value
4.1.7 The U.S. Enzalutamide Prostate Cancer Market Forecast by Value
4.1.8 The U.S. Abiraterone Acetate Prostate Cancer Market by Value
4.1.9 The U.S. Abiraterone Acetate Prostate Cancer Market Forecast by Value
4.1.10 The U.S. Leuprorelin Prostate Cancer Market by Value
4.1.11 The U.S. Leuprorelin Prostate Cancer Market Forecast by Value
4.2 Europe
4.2.1 Europe Prostate Cancer Market by Value
4.2.2 Europe Prostate Cancer Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific Prostate Cancer Market by Value
4.3.2 Asia Pacific Prostate Cancer Market Forecast by Value
4.3.3 China Prostate Cancer Market by Value
4.3.4 China Prostate Cancer Market Forecast by Value
4.3.5 China Prostate Cancer Market by Drug
4.3.6 China Abiraterone Acetate Prostate Cancer Market by Value
4.3.7 China Abiraterone Acetate Prostate Cancer Market Forecast by Value
4.3.8 China Bicalutamide Prostate Cancer Market by Value
4.3.9 China Bicalutamide Prostate Cancer Market Forecast by Value
4.3.10 China Docetaxel Prostate Cancer Market by Value
4.3.11 China Docetaxel Prostate Cancer Market Forecast by Value
4.4 RoW
4.4.1 RoW Prostate Cancer Market by Value
4.4.2 RoW Prostate Cancer Market Forecast by Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Geriatric Population
5.1.2 Rising Healthcare Expenditure
5.1.3 Surging Obese Population
5.1.4 Rapid Urbanization
5.1.5 New Drug Approvals
5.2 Key Trends and Developments
5.2.1 Growth of Pharmaceutical Industry
5.2.2 Growing Burden of Prostate Cancer
5.2.3 Advancements in Oncology
5.2.4 Increasing Public Awareness
5.3 Challenges
5.3.1 Severe Side Effects of Treatment
5.3.2 High Cost Associated with Treatment
5.3.3 Prolonged Treatment Durations

6. Competitive Landscape
6.1 Global Market
6.1.1 Revenue Comparison of Key Players
6.1.2 Market Capitalization Comparison of Key Players
6.1.3 R&D Comparison of Key Players
6.2 Approved Drugs for Prostate Cancer
6.3 Experimental Agents of Prostate Cancer

7. Company Profiles
7.1 Johnson & Johnson
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Bayer AG
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Sanofi S.A.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 AbbVie Inc.
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 AstraZeneca PLC
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 Astellas Pharma, Inc.
7.6.1 Business Overview
7.6.2 Financial Overview
7.6.3 Business Strategies

List of Figures
Types of Prostate Cancer
Symptoms of Prostate Cancer
Types of Tests for Diagnosis of Prostate Cancer
Methods of Treatment
Risk Factors for Prostate Cancer
Global Cancer Prevalence (2018-2023)
Management of Prostate Cancer Patients During the COVID-19
Global Prostate Cancer Market by Value (2015-2019)
Global Prostate Cancer Market Forecast by Value (2020-2024)
Global Prostate Cancer Market by Cancer Type (2019)
Global Hormone Refractory Prostate Cancer Market by Value (2015-2019)
Global Hormone Refractory Prostate Cancer Market Forecast by Value (2020-2024)
Global Hormone Sensitive Prostate Cancer Market by Value (2015-2019)
Global Hormone Sensitive Prostate Cancer Market Forecast by Value (2020-2024)
Global Prostate Cancer Market by Drug (2019)
Global Enzalutamide Prostate Cancer Market by Value (2015-2019)
Global Enzalutamide Prostate Cancer Market Forecast by Value (2020-2024)
Global Abiraterone Acetate Prostate Cancer Market by Value (2015-2019)
Global Abiraterone Acetate Prostate Cancer Market Forecast by Value (2020-2024)
Global Leuprorelin Prostate Cancer Market by Value (2015-2019)
Global Leuprorelin Prostate Cancer Market Forecast by Value (2020-2024)
Global Prostate Cancer Market by Therapy (2019)
Global Chemotherapy Prostate Cancer Market by Value (2015-2019)
Global Chemotherapy Prostate Cancer Market Forecast by Value (2020-2024)
Global Targeted Therapy Prostate Cancer Market by Value (2015-2019)
Global Targeted Therapy Prostate Cancer Market Forecast by Value (2020-2024)
Global Immunotherapy Prostate Cancer Market by Value (2015-2019)
Global Immunotherapy Prostate Cancer Market Forecast by Value (2020-2024)
Global Hormonal Therapy Prostate Cancer Market by Value (2015-2019)
Global Hormonal Therapy Prostate Cancer Market Forecast by Value (2020-2024)
Global Prostate Cancer Market Value by Region (2019)
North America Prostate Cancer Market by Value (2015-2019)
North America Prostate Cancer Market Forecast by Value (2020-2024)
The U.S. Prostate Cancer Market by Value (2015-2019)
The U.S. Prostate Cancer Market Forecast by Value (2020-2024)
The U.S. Prostate Cancer Market by Drug (2019)
The U.S. Enzalutamide Prostate Cancer Market by Value (2015-2019)
The U.S. Enzalutamide Prostate Cancer Market Forecast by Value (2020-2024)
The U.S. Abiraterone Acetate Prostate Cancer Market by Value (2015-2019)
The U.S. Abiraterone Acetate Prostate Cancer Market Forecast by Value (2019-2024)
The U.S. Leuprorelin Prostate Cancer Market by Value (2015-2019)
The U.S. Leuprorelin Prostate Cancer Market Forecast by Value (2020-2024)
Europe Prostate Cancer Market by Value (2015-2019)
Europe Prostate Cancer Market Forecast by Value (2020-2024)
Asia Pacific Prostate Cancer Market by Value (2015-2019)
Asia Pacific Prostate Cancer Market Forecast by Value (2020-2024)
China Prostate Cancer Market by Value (2015-2019)
China Prostate Cancer Market Forecast by Value (2020-2024)
China Prostate Cancer Market by Drug (2019)
China Abiraterone Acetate Prostate Cancer Market by Value (2015-2019)
China Abiraterone Acetate Prostate Cancer Market Forecast by Value (2020-2024)
China Bicalutamide Prostate Cancer Market by Value (2015-2019)
China Bicalutamide Prostate Cancer Market Forecast by Value (2020-2024)
China Docetaxel Prostate Cancer Market by Value (2015-2019)
China Docetaxel Prostate Cancer Market Forecast by Value (2020-2024)
RoW Prostate Cancer Market by Value (2015-2019)
RoW Prostate Cancer Market Forecast by Value (2020-2024)
Global Population Above 65 Years (2015-2019)
Global Healthcare Expenditure Per Capita (2015-2019)
Global Obese Population (2014-2019)
Global Urban Population (2014-2019)
CDER’s Novel Drug Approvals (2010-2019)
Global Pharmaceutical Market Revenue (2001-2021)
Total Number of Prostate Cancer Patients in the U.S. Rate (2018-2026)
Johnson & Johnson Sales and Net Earnings (2015-2019)
Johnson & Johnson Sales by Segment (2019)
Johnson & Johnson Sales by Region (2019)
Bayer AG Sales and Net Income (2015-2019)
Bayer AG Sales by Segment (2019)
Bayer AG Sales by Region (2019)
Sanofi S.A. Net Sales and Net Income (2015-2019)
Sanofi S.A. Net Sales by Segment (2019)
Sanofi S.A. Net Sales by Region (2019)
AbbVie Inc. Net Revenue and Net Earnings (2015-2019)
AbbVie Inc. Net Revenue by Region (2019)
AstraZeneca PLC Total Revenue and Profit (2015-2019)
AstraZeneca PLC Total Revenue by Region (2019)
Astellas Pharma, Inc. Revenue and Profit (2015-2019)
Astellas Pharma, Inc. Revenue by Product & Service (2019)
Astellas Pharma, Inc. Revenue by Region (2019)

List of Tables
Prostate Cancer Stages
Risk Factors for Severe Adverse Events (2020)
Severe Side-Effects by Type of Treatment
Revenue Comparison of Key Players (2019)
Market Capitalization Comparison of Key Players (2020)
R&D Expenditure Comparison of Key Players (2019)
Approved Drugs for Prostate Cancer
Experimental Agents of Prostate Cancer

発刊日

2020/09/26

体裁

PDF / 147ページ

販売価格

1,800USD

発行

Koncept Analytics

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

疾病別治療・領域別治療

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE